Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results
March 06, 2012 07:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...